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ABSTRACT 
Maggot debridement therapy is the application of fly larvae to a necrotic 
wound. Once popular in the 1930s and1940s, its use declined with the 
introduction of antibiotics, improvement of aseptic wound care, more aggressive 
surgical debridement techniques, and its unacceptability by the public. The 
purpose of this study was to gain a better understanding of maggot therapy, its 
clinical implications, and to review a medical chart of a Wyoming patient who 
received this treatment. The material is presented in one concise resource and 
the protocol included can be evaluated by other clinics using maggot therapy. 
A medical chart review was completed of one patient who received 
maggot therapy two years ago in preparation for a skin graft after a grizzly bear 
attack. The history, biology, mechanisms of wound healing, 
indications/contraindications, clinical uses, dressing design, and the advantages 
and disadvantages of maggot therapy are reviewed. The client included, 
responded well to maggot therapy and the wound was prepared for the graft in a 
short period of time. 
Maggot therapy is an old form of treatment that needs to be considered by 
more healthcare workers today for the treatment of non-healing wounds. If it 
were to be introduced earlier in treatments, rather than after other treatment 




The use of maggot debridement therapy to heal wounds was common 
practice in the early 190.os in hospitals nationwide, however their use declined in 
the 1940s with the emergence of antibiotic drugs, the improvement of aseptic 
wound care, more aggressive surgical debridement techniques, and the 
unacceptability of this therapeutic modality by the general public. 1,2 In recent 
years, the use of maggot therapy has once again resurfaced as strains of 
bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), have 
evolved and become more resistant to certain antibiotics.3 A study by Wolff and 
Hanson,4 felt that maggots were responsible for altering MRSA into common 
Staphylococcus aureus and then they healed the stubborn lower leg ulce·r. 
The patient included within the case study presented with a right lower 
extremity laceration as the result of a grizzly bear attack in Wyoming. This 
accident occurred approximately two years ago and the information was obtained 
from medical records and the hydrotherapy department at a Wyoming facility. 
The soft tissue injury affected the gastrocnemius, extending down to the fibula, 
and resulted in an infection. 
1 
Problem Statement 
Clinicians, as well as the general public, need to be more receptive to 
alternate treatment techniques in wound care because conservative methods can 
sometimes fail. Maggot debridement therapy is a natural form of treatment with 
exceptional healing properties that needs to be further recognized an~ accepted. 
Purpose of Study 
The purpose of this study is to gain a better understanding of maggot 
debridement therapy's history of use, biology, mechanisms of wound healing, 
indications/contraindications, clinical use, dressing design, and the advantages 
and disadvantages. In addition, a chart review of a patient who received this 
form of treatment at a Wyoming physical therapy'facility will be included. The 
case study will assist in better understanding the outcomes obtained with maggot 
therapy and it will allow other wound care facilities to compare their maggot 
therapy protocol to the one presented. 
Significance of Study 
The use of maggots is effective,however maggots are often used as a last 
resort treatment and are used in few facilities today. Therefore, the material 
presented in this study allows University of North Dakota physical therapy 
students, physical therapists, instructors, other healthcare workers, and the 
general public to gain a better understanding of all aspects of maggot 
debridement therapy in one consolidated resource. By gaining a better 
understanding of this technique through reviewing the literature and case study, 
more health care workers may be receptive to their use and learn that positive 
2 
results can be obtained through a nontraditiqnal treatment technique. If more 
conventional measures of wound care are not working with specific patients, 
maggot therapy should be considered. Maggot debridement therapy may be 
more effective if it were to be used initially, rather than as a last resort treatment. 
Research Questions 
1) What is the history of maggot debridement therapy? 
2) What are the mechanisms through which maggots help to heal wounds? 
3) How are maggots sterilized in the laboratory before they are used 
clinically? 
4) How are maggots used clinically and what type of dressing design works 
the best? 
5) What are some indications and contraindications for their use? 
6) What are the advantages and the disadvantages of maggot debridement 
therapy? 
7) What results were achieved with maggot debridement therapy on a 





Ancient surgical tools, pictographs, and fossilized bodies have proven that 
wound care was one of the oldest forms of medicine practiced by man.5 At that 
time, science coincided with religion and superstitions and therefore some 
wounds were seen as outward manifestations of evil. Treatments of these 
wounds "involved making the body uninhabitable to demons, e.g. by beating, 
starving, and torturing the patient.,,5(P47) As societies became more civilized, the 
effects of certain medications on wound healing and specific treatment 
techniques were introduced and studied. 
The infestation of wounds with maggots has been recognized for several 
centuries as well as the eventual treatment of necrotic wounds with fly larvae. 
The earliest reference made to maggots can be found in the book of Job 7:5 in 
the Bible. 6.7 "My flesh is clothed with worms and clods of dust; my skin is broken, 
and become loathsome.,,6(p474) The majority of maggot infestations, however, 
were observed on battlefields. Ambrose Pare has been credited as one of the 
earliest to observe the beneficial effects of maggots on soldier's wounds.B 
Soldiers during European wars and the Civil War were sometimes left to die on 
battlefields with open wounds, but when found several days after their injuries 
were inflicted and still alive, medical officers often found maggots residing in their 
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dying tissues. In 1829 Baron Larrey, Napoleon's military surgeon, explained, 
"these insects accelerated cicatrisation by shortening .the work of nature and by 
producing an elimination of the necrotic cells by devouring them without 
disturbing living tissue.,,9(p36) Joseph Jones, a medical officer in the American 
Civil War quoted, "I have frequently seen neglected wounds .. .filled with 
maggots ... as far as my experience extends, these worms only destroy dead 
tissues, and do not injure specially the well parts.,,10(P1143) These wounds healed 
faster than those without infestation and there were less deaths when compared 
to soldiers being treated with the therapies of that time period . . 
The first instance of therapeutically using maggots intentionally has been 
credited to J.F. Zacharias, another Confederate medical officer in the Civil War, 
in the 1860s.1,10 He noted that maggots "in a single day would clean a wound 
much better than any agents we had at our command" ... "1 am sure I saved many 
lives by their use.,,10(P1143) However, the presence of infection caused by 
anaerobic organisms such as Clostridium perfringens and Clostridium tetani 
deterred the continuation of their. use at that time.1 Finally in the 1920s, William 
S. Baer performed the first clinical study of fly larvae.11 Baer was an orthopaedic 
surgical professor at John Hopkins Medical School in Baltimore, Maryland and 
prior to his becoming a professor, Baer served as an orthopedic consultant to 
U.S. forces in France.3,4 During World War I he treated two soldiers who had 
been overlooked on the battlefield for almost a week after fighting had ceased.3 
The soldiers' wounds swarmed with maggots, however Baer recorded that the 
wounds had new or granulated tissue in them and no signs of sepsis or infection 
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was present. These observations during the war led to his studies and 
treatments using maggots ten years later. 
William S. Baer developed techniques on sterilizing maggots, designing 
food sources for them, certain treatment techniques, and dressing designs. 11 In 
his study, Baer used 89 patients with chronic osteomyelitis, a chronic 
inflammation of bone and bone marrow, in a period when the mortality rate of an 
open fracture in the lower extremity was at 75%. His subjects included both 
adults and children. The results of his study showed a 90% success rate overall 
with the total treatment time in children taking approximately six to seven weeks 
and in adults taking approximately a third longer where other treatments had 
failed. 11 ,12 Baer believed it took longer to heal adults because their new bone 
formation is slower due to a lack of growing cells. 11 In adults, there are larger 
amounts of dense bone present whereas the continual growing bone in children 
naturally aids in the repair process. It may have also taken longer in adults 
"because their osteomyelitis may have been present longer, therefore causing 
more bone destruction and larger amounts of scar tissue formation. The results 
of Baer's study are remarkable because many of his patients had tuberculosis or 
other intractable infections.12 
Baer's study led to maggot therapy in the 1930s and 1940s in nearly 300 
hospitals nationwide. 8,13,14 At this time, maggot therapy was used for abscesses, 
burns, subacute mastoiditis, and osteomyelitis.15- 21 In the 1940s, however, the 
use of maggot therapy declined for four major reasons: the introduction of 
antibiotics, the improvement of aseptic wound care, more aggressive surgical 
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debridement techniques, and the unacceptability of this therapeutic modality by 
the general public. i ,2 
The use of maggots once again resurfaced in the 1990s with the 
emergence of multiresistant strains of bacteria such as Staphylococcus aureus, 
which have caused antibiotics to be ineffective.3 Infected wounds that contain 
devitalized or necrotic tissue may not respond to antibiotics because the agent in 
the bloodstream is unable to reach the dead tissue secondary to an ineffective 
blood supply to that area. Antibiotics also do not facilitate wound debridement 
and may even retard the process if they inhibit or kill the activity of non-
pathogenic proteolytic bacteria, which naturally aid in the reduction of necrotic or 
dead tissue. In contrast to antibiotics, maggots remove both. necrotic tissue and 
bacteria , leaving. a healthy granulating wound . 
Life Cycle 
Lucilia and Phaenicia both comprise the common greenbottle blowflies.8 
The adult fly is a metallic coppery-green color hence its common name, the 
"greenbottle" blowfly.3 The word "blow" means to lay eggs and the word "bottle" 
is believed to be a form of the word "bot", an ancient word for maggot. 8 It is 
important to understand the life cycle of this particular species of fly when using 





Figure 1. Life cycle of the blow fly 
(Adapted from Sherman RA: Maggot therapy project. Available 
at: http://www.ucihs.uci.edu/path/sherman/homepg.htmi 
1995) 
The adult green bottle fly lays large numbers of eggs in clusters or what 
are known as "rafts".3.22 The larvae hatch from the eggs within 12 to 24 hours 
and are 1 to 2 millimeters in length (Figure 2). The larvae reach maturity within 4 
to 5 days, however this number varies depending on temperature, and are now 
approximately 8 to 1 0 millimeters in length, approximately the size of a piece of 
rice (Figure 2). At this time, they stop feeding and look for a place to complete 
the next stage of their development. The larvae form a puparium, which is 
produced from hardened skin. Within this new structure, the larva undergoes 
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metamorphosis and transforms into an adult fly within seven days. Once the 
adult fly has hatched, it feeds, mates, and then produces its own eggs and the 
cycle begins again. In addition to understanding this species life cycle, it is' also 
important to understand its mechanisms in wound healing. 
Figure 2. Approximate Size of maggots before and after 
Debridement. (Photo by Ronald A. Sherman, University 
of California). (Reproduced by permission from Sherman RA: 
Maggot therapy project Available at: 
http://www.ucihs.uci.edu/path/sherman/homepg.htm. 1995) 
Mechanisms of Wound Healing 
Several different theories have been suggested regarding how maggots 
cleanse and heal wounds. These include: 
1) Liquefaction of necrotic tissue by the secretion of proteolytic 
enzymes23; 
2) Digestion of necrotic tissue and microorganisms as food by 
larvae23 . ,
3) Mechanical washing out of bacteria by the serous exudate 
caused by the irritating effect of maggots in the wound8; 
4) Change in the wound r.H from acidic to alkalitic as a result of the 
formation of ammonia ,11,24; 
9 
5) Formation of granulation tissue resulting from mechanical 
stimulation of viable tissue caused by the continuous crawling of 
the larvae21 . ,
6) Intrinsic factors within the maggot causing growth-stimulating 
effects25. 
7) Destruction of bacteria by antibacterial substances (allantoin).26-
28 
Proteolytic enzymes are endogenously produced proteins that breakdown 
necrotic debris resulting from cell breakdown.29 These enzymes, whose 
activation is precisely regulated, serve many functions in normal situations as 
well as those situations which are pathological. Proteolytic enzymes are involved 
in the regulation of cell maturation and multiplication, collagen synthesis and 
turnover, the development and removal of the perivascular fibrin cuffs found in 
venous insufficiency and leg ulceration, and the removal of dead tissues after 
inflammation. It is believed that maggots produce a powerful mix of proteolytic 
enzymes, which cause a liquefication of the necrotic tissue inside the wound.3D 
The liquefied substances are ingested as well as possibly absorbed through the 
maggot's integument to be used as a food source.31 A study by Sinclair and 
Ryan29 researched the use of synthetic proteolytic enzymes being used topically 
as a form of treatment in wound care. Because most topical agents do not seem 
to penetrate the entire depth of wounds, one consideration of this experimental 
treatment should be whether or not this cream has the ability to reach desired 
targets and depths. 
A study by Vistnes, Lee, and Ksander3D on the proteolytic activity of the 
blowfly Calliphora erythrocepha/a larvae, involved the effects of larval secretions 
on experimental burns. It was shown that the secretions of these larvae digested 
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the eschar on the burned skin of experimental rats in vivo (on the living 
organism) and in vitro (in a test tube) when applied as a topical cream. The 
burns treated with larval secretion cream were further debrided than the burns 
treated with regular cream, proving that larval secretions could be a potential 
agent for the removal of burned, necrotic tissues. 
Wound pH and the presence of ammonia is another theory as to how 
maggots heal wounds. When maggots feed on meat, animal debris, and 
wounds, the odor of ammonia develops.24 A study by Robinson and Baker,24 
reviewed whether or not the ammonia found in wounds was produced by the 
maggots themselves or by the bacteria, which naturally reside in their digestive 
tract. Urea, one of the final products of protein metabolism, is found in blood and 
lymph, and therefore is present in human as well as all animal tissues.24,32 The 
enzyme urease is also found in several organisms including bacteria, fungi, 
plants, and animals.24 Enzymes are proteins that change the rate of a chemical 
reaction. 32 The ammonia is formed when the enzyme urease comes into contact 
with urea to break it down.24 The study by Robinson and Bake~4 proved that 
urease is present in both the excretions and tissues of Lucilia sericata (sterile 
and non-sterile larvae), the species of blowfly used in wound care today. The 
urease that is present in the maggot excretions comes into contact with the urea, 
which is present in the wound bed of the patient. Ammonia is formed by the 
joining of these two substances and therefore produces an alkaline environment 
inside the wound. William S. Baer and others have proven that "wounds with an 
alkaline reaction healed faster than those inclined to be acid.,,11,24(p149) Baer 
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noted that most wounds have an acid reaction but once the maggots were 
introduced into a wound, it took only about 24 hours to become alkaline.11 He 
believed alkaline wound beds caused sterilization of the wound and the killing of 
any bacteria present. 
Another theory as to how maggots heal wounds, involves the possible 
secretion of growth factors by maggots. A study by the Department of Veterans 
Affairs Medical Center in Long Beach, California25 researched the growth effects 
of Phaenicia sericata larval extracts on fibroblasts. This study exposed human 
fibroblast tissue culture to hemolymph (blood and lymph) as well as alimentary 
extracts from the maggots. The growth effects of maggot extracts were 
compared to those of epidermal growth factor, recombinant interleukin 6, and the 
insect hormone 20-hydroxyecdysone. This study found that maggot extracts 
stimulated significant increases in human fibroblast numbers, therefore 
suggesting that maggots have intrinsic factors that might be responsible for the 
growth stimulating effects seen in wounds infested with maggots. The release of 
these growth factors by the maggots may be responsible for the stimulation of 
new granulation tissue.33 However, the stimulation of newly granulated tissue 
may also be due to the constant movement of the maggots within the wound. 1 
One final theory as to how maggots debride wounds and promote wound 
healing includes the destruction of bacteria in the wound through excretions, 
which contain antibacterial substances. A study from 1934 by William 
Robinson26 determined that urinary excretions from both sterile and non-sterile 
maggots contain allantoin. Allantoin is the principle terminal product of purine 
12 
'metabolism and results from the oxidation of uric acid. It not only is found in 
maggot urinary secretions but also is common in plants and animals. The 
allantoin for the study was obtained commercially and was applied to ulcers, 
burns, and wounds with little granulation. Local granulation was found where the 
allantoin was applied after just a few treatments. 
It has been researched that several other species of insects possess the 
ability to produce antibiotic-like agents.34 Studies on the screw-worm, a species 
not used in maggot therapy, suggest that antimicrobial agents including 
phenylacetic acid and phenylacetaldehyde are formed by the bacterium Proteus 
mirabilis. Proteus mirabilis naturally resides in the gut of the screwworm and it is 
believed that the bacteria remaining in the wound bed, which are not ingested, 
are killed by chemicals produced by this bacterium.35 This bacteria may be the 
one responsible for the killing of the bacteria in the wound bed. 
There are still many unanswered questions as to the exact mechanism 
,that maggots use to cleanse and heal wounds. It may only involve one of the 
theories listed above or it may be a combination of several. 
Maggot Sterilization 
The purpose of using maggots in wound care is to clean out any existing 
infection and/or necrotic tissue therefore, it is important that the maggots be 
sterile so they do not introduce additional bacteria. Sterile medicinal maggots 
indicate that the maggots to be used in therapy are "disinfected" or free from 
bacteria.36 Although sterile, maggots are still capable of maturing into adulthood, 
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however it should be remembered that maggots are sexually immature and are 
incapable of reproduction until they have pupated into adult flies. 
William S. Baer was the first to clinically study maggots and he was the 
first to develop a process in sterilizing them in the laboratory.11 Initially Baer 
attempted to sterilize the maggot itself rather than the egg. Through several 
trials, he found that the intestinal tract did not become sterilized with this method 
and that is where some bacteria reside in the maggot. This method did not work 
because only the external surface of the maggot became sterilized and not the 
inside. Baer decided that the egg must be sterilized in order for the process to 
work. The test tubes used to house the eggs were sterilized in hot air at 160°C 
for one hour. The eggs were then divided and placed into di~erent test tubes. 
Next, the sterilizing solution of ethyl alcohol, hydrochloric acid, and mercury 
bichloride was poured over the eggs in the test tubes. The eggs were immersed 
in this solution for a total of thirty minutes. In order to wash the eggs, they were 
first strained with gauze and then sterile distilled water was poured over them. 
Finally, the eggs were transferred to bottles that contained sterile food. The 
sterilized food consisted of agar culture media liquefied, Fleischmann's yeast, 
and pig liver. The liver was chopped up into cubes, covered with water, and was 
allowed to boil for twenty minutes. The yeast was added to the liquefied agar 
and then was poured over a cube of liver inside a bottle. The bottles, each 
containing a cube of liver, were then sterilized for thirty-five minutes at fifteen 
pounds' pressure. Next, the bottles were incubated at 37° C for thirty-six hours 
and then were sterilized again for the same amount of time and pressure. 
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Today, different companies have different methods of sterilizing maggots, 
but all include methods similar to Baer's method of sterilization. One method 
included in an article by Teich,37 involved washing the eggs three times with 
water after removing them from their food source. The eggs were then sterilized 
with three washes of a solution of sodium hypochlorite (Clorox) diluted 1 :50, and 
then they were hatched in a sterile flask. 
A study by Sherman and Wyle38 stated that they disinfected their eggs by 
washing them for five to six minutes with 3% Lysol and then three rinses with 
sterile saline. The eggs were then separated from one another by soaking them 
in sodium sulfite or sodium hypochlorite. They believed it was crucial to 
individually separate the eggs from one another before disinfection because 
otherwise bacteria can become trapped within the egg masses and the 
disinfectant will not penetrate this area. Baer also believed the separation of 
eggs was necessary before pouring the sterilizing solution over them and he 
separated the eggs by stirring the eggs in water.11 Next, they placed the hatched 
maggots in a sterile container that contained the food source of sterile raw 
chicken.38 
A study completed by Mumcuoglu et al2 "surface sterilized" their maggots 
with 1 % sodium sulfite in physiological saline that contained 2.5% formaldehyde. 
Next, the eggs were transferred to a container that consisted of a mixture of 
pureed liver, and agar containing kanamycin monosulfate. After hatching, the 
larvae were washed with sterile distilled water. After washing, they were surface 
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sterilized again with 3.5% formaldehyde in physiological saline, washed with 
distilled water, filtered through a sieve, and stored in sterile Eppendorf tubes. 
In order to make sure their sterilizing process was successful, some' 
facilities that raise maggots have their maggots cultured in a laboratory before 
they are sent off for use in clinics. 39 The facilities that raise the maggots may 
have their own laboratory equipment ·available for culturing or they may send the 
maggots to be sampled at a local hospital. 
Indications and Contraindications to Maggot Therapy 
Today, a majority of patients treated with maggot therapy have ulcers, 
pressure sores, or traumatic wounds which have become infected. These ulcers 
include diabetic foot ulcers (arterial ulcers), venous stasis ulcers, and other 
neurovascular ulcers.39 Ulcers can develop, for example, in patients with 
diabetes who have poor circulation. Pressure sores develop in patients who 
have been bed-ridden for extreme periods of time and therefore their blood 
pools. Poor circulation or pooling blood can lead to tissue cell death and 
therefore necrotic tissue develops. Maggot therapy is also used for patients who 
require pre-surgical debridement and for those patients with post-surgical 
wounds that are not healing with other forms of wound treatment. 39 It can also 
be used for osteomyelitis,11 as Baer researched years ago, as well as for any 
gangrenous tissue. 39 Gangrene is the death of tissue cells secondary to the 
blockage of blood supply to a wound and if it is not removed, the tissue will rot.40 
Maggot therapy is also indicated for wounds that have antibiotic resistant strains 
of bacteria like methicillin-resistant Staphylococcus aureus.41 Other uses have 
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included cellulitis, mastoiditis, abscesses, cancerous tumors, and recently 
maggot secretions have been used to treat burns.9,21,23,3o In cases where maggot 
therapy was used to treat cancerous tumors, it should be noted that maggots 
cannot be used as a cure for cancer but studies do indicate they may decrease 
tumor size or can be used for palliative care.3 
Maggot therapy is not appropriate for all patients and certain 
contraindications should be considered before its use. Maggot therapy should 
not be used on wounds that bleed easily and they should not be placed in 
wounds that are located near large blood vessels or those associated with a 
body cavity or organ.39 One final contraindication involves the psychological 
status of the patient. If the patient is unable to handle the idea of maggots as a 
form of therapy, then they are not a candidate for this form of treatment. 
Clinical Use 
The species of fly larvae used clinically today is Phaenicia Sericata (green 
blowfly) or Lucilia sericata.3,39 Any licensed physician can prescribe maggot 
therapy in the clinic, but most commonly, plastic surgeons or orthopedic 
surgeons will order their use. Some physicians apply the maggots themselves, 
but physical therapists, nurses, nursing assistants, and even entomologists can 
apply them.22 The patient will have consented to their use prior to beginning 
treatment and they will be informed on their use and what is expected with this 
form of therapy. 
Prior to applying maggots in the clinic, the size, shape, amount of exudate, 
and the odor of the wound should be recorded. It is important to measure the 
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wound's length, width, and depth as well as the amount of necrotic tissue and 
newly granulated tissue present. Sometimes wounds are traced onto a sterile 
plastic sheet with a grid to keep in the patient's chart. The number of maggots 
that should be introduced into the wound is dependent on the wound's size.3 A 
general rule is that no more than ten maggots per centimeter squared should be 
applied to a small wound and even less if there is a smaller amount of necrotic 
tissue present. 
The maggots arrive in a sterile container with a Iid.39 The lid contains a 
filter that allows air to enter but not microorganisms. They are usually ordered in 
units and one unit contains approximately 1000 maggots at a price of 
approximately $80. Within the sterile container, there is a 4 x 4 soaked with 
nutrients to provide a moist and somewhat humid environment. Occasionally 
upon arrival some of the maggots may have dried up and died and will look like a 
black speck. Most companies who supply facilities with maggots will ship them 
overnight for next day delivery. It is generally a good idea to use the maggots 
within one day after their delivery, but if they are not used immediately they can 
be kept up to five to seven days if properly stored in a refrigerator at or slightly 
above 5 to 6 cG. While refrigerated, a moist gauze pad should be placed in the 
container every so often to keep them moist so they will not dry out. The maggots 
should also be removed from the refrigerator twice a day for one hour to prevent 
them from freezing. The application technique and the dressing design vary 
among facilities and the company who provides them. 
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To apply maggots to the wound, the maggots can be swiped from the vial 
onto a saline-soaked 4 x 4 pad and then loosely pack the 4x4s into the wound 
bed. The gauze application of the maggots allows for easy handling of the 
maggots and gives the maggots a "larger area through which to crawl before 
reaching the wound margins and escaping.,,42(P453) Another method to remove 
the maggots from the vial is to pour a small amount of saline into the vial with the 
maggots.39 Swirl the saline around in the vial to loosen the maggots from the 
sides of the vial. Then, strain the vial contents over a piece of chiffon, remove 
the maggots from the chiffon with a tongue depressor and then place inside the 
wound. Once the maggots are placed inside the wound bed, the maggots have a 
tendency to congregate together and they use their mandibles to latch on to the 
necrotic tissue on which they will feed .3 Next, the dressing is applied to the 
wound and includes a "cage-like" design. The dressing should not only contain 
the maggots, but also allow oxygen to enter and the liquefied necrotic tissue 
produced by the maggots to seep OUt.42 The maggots are left in place anywhere 
from 24 to 72 hours.39 If the larvae are left in the wound longer than this amount 
of time or after they are satiated, the next stage of development (pupation) will 
OCCUr.
36,42 If the maggots try to pupate within the wound they will do so in either 
the tissue itself or in the gauze that is inside of the wound.36 If the dressing 
becomes loose during the treatment time, then the edges of the dressing should 
be taped down with a hypoallergenic tape to prevent further escaping.39 If the 
entire dressing comes off, then the patient should come in to the clinic and the 
process of application should be repeated. 
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After 24 to 72 hours, it is time to remove the maggots from the wound. A 
red biohazard bag should be placed next to the wound, or if it is an extremity, 
within the bag itself. The dressing is removed and the wound is rinsed with a 
bottle of saline. By rinsing the wound into the bag, the maggots and dressings 
are quickly and properly contained and environmental services can be contacted 
to properly dispose. It is not recommended to use a whirlpool or Hubbard tank 
for the removal of the maggots because the maggots can get into the whirlpool's 
agitator. This would make it hard to clean and the chemicals used in cleaning 
the whirlpools may not kill the maggots thoroughly. Once the dressing is 
removed, the 8 to 11 mm maggots now full of food, may be seen feeding in the 
"head down" position and tunneling tracts may be noted.3 The amount of necrotic 
tissue will determine the number of sessions needed with maggots, as ordered 
by the patient's physician.39 Nearly half an ounce of dead tissue can be digested 
each day by the average dose of maggots.43 The process of therapy may need to 
. be repeated once or twice a week or until the wound is healed. Sometimes one 
session is sufficient, whereas wounds with large amounts of necrotic tissue may 
need several weeks of therapy.3 Indicators that maggot therapy should be 
discontinued are a decrease in wound odor, decreased wound drainage, and 
healthy red granulating tissue in place of the necrotic tissue.39 A majority of 
clinics discharge maggots when the-wounds are free of necrotic tissue, however 
William S. Baer continued their use until the wound was completely filled with 
granulation tissue. 11 By extending the maggot's use, re-infection with bacteria 
may be prevented as well as the build-up of sloughy debris. One clinic noted that 
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the maggots have a tendency to leave behind a "silvery-slimy tissue" that they do 
not want to ingest. Because of this, it is necessary to use another form of 
debridement in addition to the maggots. In Baer's study,11 it was felt that a 
"scum" left over the newly granulated tissue may be due to Proteus bacillus, a 
persistent bacteria that remained in the wound. 
Dressing Design 
The maggot therapy dressings used 60 years ago were rather elaborate, 
time consuming, and expensive.42 Today, the types of dressings used in maggot 
therapy will vary among facilities and the materials available. Most facilities find 
that dressing design is a process of trial and error and is a technique learned 
from mistakes. Selection of the dressing is an important part of this type of 
treatment and several things should be kept in mind when designing the 
dressing. 
The dressing should be "cage-like" in order to keep the maggots from 
escaping the wound bed throughout the course of treatment. It is important to 
keep the maggots within the wound because they may leave the wound once 
they are full or when it is time to bury themselves for pupation, the next stage in 
their development.42 The dressing should allow oxygen to enter the wound bed 
but at the same time should absorb liquefied necrotic tissue that the maggots 
have produced . The dressings should be easy to apply, simple to maintain, 
durable, and inexpensive. Sometimes the powerful proteolytic enzymes that the 
maggots secrete cah be irritating to healthy tissue causing the surrounding tissue 
to become red and this should be considered when constructing a dressing 
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design in maggot therapy.3 This redness may be due to the maggot secretions 
or it may be a bacteria present on the wound borders that is not visible to the 
therapist but is recognized by the maggots. 
One type of dressing design suggests surrounding the wound with 
DuoDerm, a type of hydrocolloid dressing, and then applying a layer of Mastisol 
over the DuoDerm.39 DuoDerm provides a moist healing environment, however 
maceration may occur with large amounts of wound exudate.44 After the 
maggots are placed inside the wound, a piece of chiffon, larger than the wound, 
is put in place over the DuoDerm.39 The chiffon is secured with another layer of 
. Mastisol followed by DuoDerm. Next, a 4 x 4 is placed over the previous, or if 
the wound is on an extremity, a Kerlix roll can be used to hold everything in 
place. 
Another dressing design that may be quicker than the previous, fits a 
piece of Derma-net over the wound bed once the maggots are in place. The 
Derma-net is edged with Hypa-fix tape, a cloth-like tape, to prevent maggots from 
escaping the edges of the dressing. Next, an ABO pad is put into place and then 
burn net is used to hold the entire dressing in place. 
Other designs have been made using hydrocolloid dressings and zinc 
paste bandages to better contain the maggots.3 Sometimes, hydrocolloid 
dressings cannot be used because of a wound's location or if the patient has 
overly sensitive skin. In this case, a zinc paste bandage can be used in place of 
the hydrocolloid. A dressing design that uses hydrocolloid, described cutting a 
piece of hydrocolloid to fit the wound size. Next, a sterile piece of fine nylon 
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mesh was cut larger than the wound size but smaller than the al"ready cut 
hydrocolloid dressing. The nylon mesh was taped to the back of the hydrocolloid 
dressing. To cover the hydrocolloid, an absorbent pad was put in place to 
absorb any exudate from the wound. This outer absorbent pad is beneficial 
because it can be changed without disturbing the primary dressing. 
A study by Ronald Sherman42 described his "most successful" dressing 
design (Figure 3). This technique first applied DuoDerm directly to the skin 
surrounding the wound with a hole cut in the center of the dressing to surround 
the wound. Next, two coats of Skin Bond Cement were spread over the 
DuoDerm. The maggots were then introduced to the wound through the opening 
that was cut into the center of the DuoDerm. A sterilized piece of chiffon was 
placed over the DuoDerm and wound bed and was glued in place with the 
cement. Next, silk tape was placed along the chiffon to further adhere the 
chiffon to the' DuoDerm. Finally, a transparent ring of semipermeable membrane 
sheet was placed over the silk tape and over part of the surrounding skin. A 
semi-permeable membrane film is a transparent tape-like substance. It is 
permeable to moisture vapor and oxygen but not to bacteria and water.44 This 
final layer was put into place to help protect the dressings from soiling and to "act 
as an effective second-line barrier to the occasional maggot that managed to 
navigate between the skin and the DuoDerm.,,42(p453) A final gauze pad was 
placed over this entire design to absorb any drainage produced from the wound 
and could be changed every so often as needed. If the top gauze pad were left 
in place too long, it would become too moist from excessive exudate and would 
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cause the dressings below to loosen. This study proved this dressing design to 
be very successful and reduced the frequency of maggots escaping to less than 
one percent of all maggot dressings applied. The average length of time to apply 
this type of dressing was approximately 30 to 45 minutes. Although this dressing 
design is time consuming, the prolonged survival rate of this dressing and the 
reduced frequency of maggots escaping "have more than compensated for the 
extra effort required to construct it.,,42(p454) This dressing design is also worth the 
time in its construction because it allows the wound bed to be directly observed 
throughout the patient's treatment. One disadvantage of this dressing design 
would be that if a large number of maggots were introduced to the wound and the 
dressing was applied too tight, pressure damage could result. If the wound is 
located in an area where a hydrocolloid ring or a sheet of chiffon are unable to be 
used, then a nylon stocking can be applied. The stocking has the advantage 
over the chiffon of stretching, therefore allowing the wound to expand. Sherman 
also found that by coating the surrounding skin of the wound bed with a skin 
protectant like Shield Skin, the tissue was less likely to become inflamed and the 
adherence of the DuoDerm was also improved. 
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Figure 3. Optimal maggot debridement therapy dressing design 
(Reproduced with permission by Sherman RA: A new dressing design 
for use with maggot therapy. Plast Recontr Surg. 100:451-456, 1997) 
. A study by Thomas and Andrews,45 examined the effects of hydrogel . 
dressings on maggot development. Hydrogels are "three-dimensional, water-
swollen, cross-linked structures" which have the "ability to absorb or donate fluid, 
depending on the nature of their formulation and the state of hydration of the 
wound.,,45(p75) They are thought to "promote autolytic debridement by increasing 
the moisture content of slough and necrotic tissue, thus facilitating enzymatic 
activity.,,45(P75) This study was made because many times maggot therapy is 
used as a last resort treatment method and therefore traces of other products in 
the wound are left from prior treatment methods. It was believed that certain 
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brands of hydrogel were having effects on the development and survival of the 
larvae in the wound. The study examined the effects of six different brands of 
hydrogel: Aquaform, Granugel, Intrasite, Nugel, Purilon, and Sterigel. Fresh 
pig liver was blended with different percentage amounts of the six different 
brands of hydrogel. Next, the larvae were introduced to each sample and left to 
feed on the liver for 48 hours. At the end of the 48 hours, the larvae were 
counted and weighed. All the gels but one contained propylene glycol, therefore 
it was necessary to carry out a second study to determine the effect of this 
substance on larval survival and development. Propylene glycol is added to gels 
in order to prevent the gels from drying out and also to prevent the growth of 
microorganisms. 
The studl5 found that there was reduced larval growth and there also was 
an increase in the mortality of the larvae with increased concentrations of 
Granugel, Intrasite, Nugel, and Sterigel. With Aquaform, this trend was reversed, 
however there still was a decrease in larvae development when compared to 
control values. Purilon gel was found to increase the development of larvae 
when compared to control values and this is believed to be true because of the 
absence of propylene glycol. When propylene glycol was added to the 
liver/Purilon gel mixture in the second part of the study, there was a marked 
decrease in the development of the maggots. When propylene glycol was added 
to the liver alone, an even further decrease in larval development was noted. 
This study also found that when water was added to both the liver/gel mixtures 
and to the liver alone, the larvae survival and growth rates decreased. It should 
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be remembered that maggots feed by secreting enzymes which dissolves any · 
dead tissue, turning it into a "liquid soup", which makes for easy ingestion. "In 
the presence of excess liquid, it is postulated that, if the maggots do not drown, 
their digestive enzymes become diluted and therefore rendered less 
effective. ,,45(p77) "The increase in larval development observed with increased 
quantities of Purilon gel may be attributed to the ability of the gel to absorb 
excess fluid from the blended liver, resulting in the formation of an increasingly 
cohesive mass.,,45(p77) Like the Purilon gel, Aquaform also reduced the fluidity of 
the macerated liver and this decrease in water content may be responsible for 
the increased survival rate of the maggots. This study would be important for 
health care workers using maggots to keep in mind if they fee.! they are not 
getting the results usually presented. 
Patient Education 
Patient education is crucial in any type of healthcare, especially in physical 
. therapy. When first explaining to a patient that maggots are going to be used for 
treatment, most patients have mixed feelings. It is critical that the patient 
understands the entire process of maggot therapy prior to initiating their 
treatment. 3 It is also important to show the patient the actual size of the maggot 
to be introduced to their wound. Most facilities have a brochure or video on 
maggot therapy that is reviewed with the patient prior to beginning treatment. 
Begin by explaining the type of maggot to be used in treatment and the 
mechanism of their wound healing process. All species of maggots are not 
identical in their actions. Some burrow into healthy tissue, while other species 
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digest only necrotic tissue.22 Explain that the maggots are sexually immature, 
are disinfected, and that they will be removed before it is time for the next stage 
in their development (pupation).36 Also explain that the maggots will not enter 
their bloodstream while inside of the wound bed. Let the patient know that they 
may feel the maggots moving around inside the wound, a tickling sensation, but 
that it is normal.46 This tickling sensation can be a downside to maggot therapy, 
however a majority of patients treated with maggots have diabetes and therefore 
have poor sensation in their extremities. The odor during this form of therapy 
can be quite offensive the first few days because the maggots have stirred up the 
bacteria in the wound. 11 Odor should decrease as the treatments progress 
because the maggots feed on the bacteria causing the tissue: death. Sometimes 
a wintergreen spray is given to patients to spray on their outer bandage to help 
mask the strong odor. Patients will also be concerned with whether 'or not 
treatment will be painful. Explain that a majority of patients feel that their wound 
pain is reduced or completely eliminated during maggot therapy.3 Cost is 
another big concern of patients and they should understand that maggot therapy 
is generally cost effective. 
Most healthcare workers, who have used maggot therapy as a form of 
treatment, have found patients to be remarkably tolerant of their use.46 As a 
health care worker who is providing this type of treatment, it is important to act 
confident with what you are doing.43 If the patient senses you are uncomfortable, 
they will be uneasy with treatment as well. 
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Advantages and Disadvantages of Maggot Therapy 
The advantages of maggot therapy outweigh the disadvantages and with 
an increase in resistance of certain types of bacteria to antibiotics, clinicians 
nationwide need to consider alternative methods of wound management. 
Although sterilized maggot treatments can be costly, this treatment is cost 
effective in the end.3 For example, a 72-year old man diagnosed with bilateral 
chronic foot ulcers located on his metatarsal heads was treated for twelve 
months with conventional measures.12 These conventional methods included: 
silver sulfadiazine cream 1 %, saline dressings, unna boot therapy, topical 
enzymes, topical antibiotics, intravenous antibiotics, sodium hypochlorite 0.5%, 
hydrocolloids, hydrogels, foams, and calcium alginate dressings. After twelve 
months, no signs of healing were noted. This patient was then entered into a 
maggot therapy study in 1993 where the left foot was to receive maggot therapy 
twice a week and the right foot was to continue with the conventional met~ods of 
treatment. By the fourteenth week of the study, the left ulcer was almost 
completely healed where the right ulcer remained unchanged. This specific 
study reveals how maggot therapy is cost effective because of decreased 
treatment time in the clinic. Maggot therapy is also cost effective because it can 
be done as an outpatient; therefore the patient does not have to pay for overnight 
stays or nursing fees and may even prevent a costly amputation.33 
Another advantage of maggot therapy is that it takes less time than 
surgical debridement and the healthy tissue is not damaged. Surgical 
debridement is a type of semi-selective debridement meaning that both necrotic 
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and living tissues are removed together, ideally more necrotic tissue being 
removed than viable tissue.44 Maggot therapy is a type of selective debridement, 
meaning only necrotic tissue is removed. Therefore selective debridement is 
much more advantageous than semi-selective debridement. 
Other advantages of maggot therapy are that no anesthetic is necessary 
and it is less painful than other methods of debridement.47 Maggots also do not 
require an excellent peripheral blood supply,31 which is beneficial for patients with 
diabetes. The maggots also may actually initiate new tissue growth by secreting 
growth promoting agents.21 ,25 Maggots are also universally available.31 
One of the main disadvantages of maggot therapy is aesthetic in nature.31 
It is hard to convince some clinics and patients to use maggots because they are 
often associated with dirt, decay, and/or death.3 On a recent episode of an 
emergency room television series, a patient with gangrene was being treated 
with maggots 30 mm in length, causing the patient to become hysterical. It is no 
wonder that patients, as well as clinicians, are skeptical about their use when the 
actual average size of maggots used in therapy is 2-3 mm in length. Another 
disadvantage may include a localized pruritis, or itching, however most patients 
are unaware of the maggots presence.31 A skin irritation may also develop 
secondary to the strong proteolytic enzymes released by the maggots.3 A 
summary of the advantages and the disadvantages are listed in Table 1. 
As of today, maggots are generally used as a last resort treatment method 
for stubborn wounds that will not heal. After weighing the advantages to the 
disadvantages, it is clear that maggots should become a regular form of 
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treatment in wound care facilities worldwide . . If maggot therapy were to be used 
earlier in treatment in place of conventional methods of wound care, it could 
become even more effective in results and in controlling costS.47 
Table 1. Summary of the advantages versus the disadvantages of 
maggot debridement therapy 
• Cost effective 
• Selective debridement 
• Can Rx as outpatients 
• No anesthesia necessary 
• Less painful 
• Universally available 
• Good peripheral blood 
supply not necessary 
• May initiate new tissue 
rowth 
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• Aesthetic in nature 
• Localized pruritis (itching) 
• Patients may feel their 
crawling/tickling 





Two databases were used to locate journal articles pertinent to this study. 
Medline is a database that includes articles from international biomedical journals 
of all languages and includes publications from 1966 to the present. A majority 
of the references used for this study were located using this database at the 
Harley E. French Library of the Health Sciences, University of North Dakota. 
Infotrac's Health Reference Center was another database used at Coe Library, 
located at the University of Wyoming. For journal articles that were not available 
at the University of North Dakota, interlibrary loan was used. The Internet was 
also useful in locating articles and pictures of maggot debridement therapy. 
In addition to the databases and Internet, a company that supplies the 
Wyoming facility included within the case study with their maggots was contacted 
with a phone call. This company, biomaggot.com, Inc., provided a pamphlet of 
information regarding maggot therapy and how to use their product clinically. 
Interviews with a physical therapy assistant who works in the hydrotherapy 
department were also made on several occasions to answer questions as they 
arose throughout the research process. Observation of the application of maggot 
therapy to a patient was made possible at the hydrotherapy department. This 
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treatment was applied to a patient other than the one included within the study, 
however through this observation, the application technique was further 
understood. 
Procedure 
A physical therapist at the Wyoming facility's hydrotherapy department 
was contacted with a letter describing the proposed project by the researcher. A 
phone call was also made to the medical records office at this same facility. 
Once the University of North Dakota's Institutional Review Board (IRB) approved 
the proposed project, a copy of it was given to the medical records office. This 
proposed study was presented to the hospital's lawyer and permission was 
granted. Both departments were willing to participate once permission was 
approved. Because the copying of any clinical photographs taken in 
hydrotherapy was not included within the original proposal, a memo was sent to 
the University of North Dakota to inform them of the change. The University 
permitted the changes and a copy of the signed memo supporting the change 
was given to the medical records office. While all of the paperwork was being 
processed, articles were gathe~ed from the two databases. 
Once all of the paperwork was cleared, copies were made from the 
subject's chart in medical records at the Wyoming facility. Copies of the subject's 
initial hospital notes (where the subject was first admitted immediately following 
the accident), EMS reports, radiology reports, surgical reports, physician's 
orders/evaluations/discharge notes, and physical therapy/hydrotherapy 
reports/notes were made. These copies were reviewed to gain an understanding 
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of the subject's accident and the medical procedures performed after the 
accident occurred. The subject was contacted and informed of the study and the 
subject provided informed consent for the release of medical records and any 
photographs taken in hydrotherapy. The subject was contacted with questions 
that could not be answered after the chart was reviewed. Copies of the 
photographs taken in hydrotherapy were made after patient consent and were 
helpful in viewing the progress made in hydrotherapy. 
Subject 
Selection 
One subject, who underwent maggot debridement therapy at a Wyoming 
facility two years ago, was selected for this study. The subject provided written 
consent to allow the review of his chart at the Wyoming facility's medical records 
office (Appendix). The subject also provided written consent to allow copies to 
be made of photographs taken en the hydrotherapy department at this Wyoming 
. facility. 
At the time of the intervention, the subject was in good physical condition, 
had a non-significant past medical history, and had no coexisting medical 
conditions that would interfere with his hydrotherapy treatments. This subject 
was recommended by the hydrotherapy department because of the positive 
results achieved through maggot debridement therapy, his good physical and 
mental condition, his local residency, and because no other coexisting medical 
conditions interfered with his treatments. A majority of patients treated in 
hydrotherapy are elderly and have coexisting medical conditions that sometimes 
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interfere with their treatments and on occasion death precedes the completion of 
their treatments. Because the subject lives locally, any needed information could 
easily be obtained if questions came about. 
The hydrotherapy department initially contacted the subject by phone to 
see if he would be willing to release his medical information for the inclusion 
within the study. The department gave the subject the researcher's phone 
number and contact was made that day. A meeting with the subject was 
necessary so the study could be described in detail prior to informed consent and 
the consent form could be signed. 
Client History 
The patient was a 40 year-old white male who works fulltime, enjoys 
outdoor activities, and is married. He has a past medical history of seizures and 
a left medial collateral ligament (MCl) repair with screws in 1976 and his 
medications at this time were not significant. 
The patient was camping alone in a Wyoming park when he encountered 
a grizzly bear. The bear bit him on the right lower extremity, scratched him on 
the abdomen, and threw him into the air before being driven off with pepper 
. spray. The patient had to hike out of the park alone and then he drove by himself 
for several miles to a nearby hospital. Upon examination in the emergency room, 
it was evident that the patient had sustained a huge laceration to the right lower 
extremity. The wound extended from the proximal tibia in a semi-circular fashion 
to the distal one-third of the lateral tibia, resembling an "s" shape. The wound 
extended through the gatrocnemius muscle down through to the fibula. Neither 
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foot drop nor decreased sensation was present. The peroneal nerve and the 
vasculature to the leg were all intact and normal. X-rays of the right lower 
extremity revealed no fractures or osseous deformities, however significant 
amounts of gas were present as well as soft tissue swelling secondary to the 
laceration. The bear claw scratches to the abdomen were superficial and did not 
present a problem. While in the hospital, the patient received surgery the day of 
the accident. The wound was debrided and a pulse lavage was used to irrigate 
the wound bed. The loose flaps of skin were approximateq with sutures and a 
drain was put into place. Several 4x4s soaked with Betadine, an anti-infective, 
were applied to the wound along with a leg splint. The following day, further 
debridement was performed in the operating room along with pulse lavage and 
the wound was once again partially closed with sutures. Betadine 4x4s were 
applied along with Kerlix gauze rolls and an Ace wrap. In addition to the two 
surgeries, a tetanus vaccination was administered at this facility. 
Two days after the accident, it was felt that the patient was strong enough 
to travel via private vehicle to a larger hospital located in the patient's hometown. 
En route to the larger hospital the wound began to hemorrhage and an 
ambulance was called to intercept the vehicle and complete the trip . . In the 
ambulance the patient was put on oxygen, a pressure dressing was applied, and 
the lower extremity was elevated. Upon arrival at the second facility, the patient 
was given one unit of blood and pain medications. The examination at the 
second hospital revealed that the wound flap, which had been sutured at the 
initial hospital, was slightly bluish in color and the wound bed had a slow capillary 
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refill. No purulent discharge or odor was present at this time. Because the skin 
flap was necrosing, it was anticipated that a split-thickness skin graft (STSG) 
would be necessary in the future. The physician predicted that there would be 
complications with infection because grizzly bears are omnivores and predators, 
therefore their mouths and claws are exposed to microorganisms foun9 in the 
prey they eat and the dirt they forage: 
The patient was kept on bed rest the first few days in the hospital in the 
Trendelenburg position, where the head is slightly lower than the lower 
extremities. The wound was left open and the circumference of the wound was 
measured on a daily basis. The sutures applied at the first facility were removed 
at this time and some initial improvement in the color of the flap was noted. 
Evaluation/Examination 
Five days after the accident, on September 3, 1998, an evaluation for 
hydrotherapy' was completed and the patient was ordered to receive 
hydrotherapy on a daily basis. Upon initial evaluation, no odor was present, and 
drainage was minimal and sanguineous. The color showed black and white 
slough throughout the wound bed with areas of blue between the three open 
lacerations. Therapists were unable to accurately assess the amount of necrotic 
and granulated tissue at this time. There were three different open lacerations 
and their measurements were taken. The medial proximal open laceration 
measured a length of 2 cm (centimeters) and a width of 4.2 cm. The medial 
distal open laceration measured a length of 11 cm and a width of 1.8 cm. The 
most lateral open laceration measured a length of 27 cm and a width of 4 cm. 
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Range of motion (ROM) in the right ankle anp knee were limited and the ankle 
was held in plantar flexion when the patient was resting. There was no sensation 
present in any of the open laceration areas. The patient's mobility was 
decreased and the patient did not bear weight on the right lower extremity. A 
front-wheeled walker was used as an assistive device. A problem list was made 
and included: 1) Lacerations to right lower extremity, 2) Necrotic tissue present, 
3) Edema, 4) Decreased ROM in the right lower extremity. Goals were set and 
included: 1) Decrease edema with elevation, increased weight bearing, and 
increased ROM, 2) Debride sloughing tissue as needed, 3) Increase ROM with 
weight bearing and therapeutic exercise, 4) Patient to be independent with 
therapeutic exercise, weight bearing, and gait. The treatment plan was to see 
the patient on a daily basis for whirlpool, therapeutic exercise, ROM, patient 
education, debridement, and dressing changes. On the day the evaluation was 
performed, the patient was treated in the Hubbard tank for twenty minutes and 
the wound bed was lightly cleaned with a 4x4 while the leg was immersed in the 
water. 
Treatmentll ntervention 
The patient arrived the day after the initial hydrotherapy evaluation was 
performed ambulating with a cane. At this time, the patient had been discharged 
from the hospital and was being seen as an outpatient by hydrotherapy. For the 
first five treatment sessions, the patient was treated for twenty minutes in the 
Hubbard tank and the wound was dressed with SoftSorb pads or Xeroform, an 
ABO pad and burn net. Range of motion exercises and heel cord stretches were 
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also initiated at this time. It was noted that the entire flap of skin, which had been 
surgically reattached after the accident, was becoming necrotic. It was decided 
by the plastic surgeon after the first five treatments that maggot therapy would be 
initiated to prepare the wound bed for the STSG to be performed at a later date. 
Prior to applying the maggots, the plastic surgeon debrided the middle portion of 
the black, necrotic flap of skin to allow room for the placement of the maggots. 
The necrotic borders of the wound were left alone so that the healthy surrounding 
tissue would not be damaged. The maggots were used for a total of four 
treatment sessions and were replaced every third day or every 48 hours. The 
maggots were inserted into the wound bed via saline soaked 4x4s. The netting 
was secured with hypa-fix tape, and then an ABO pad for collecting drainage, 
and burn net were put into place. The patient and his spouse were instructed on 
the proper care of the maggots, how to change the top dressing (ABO and burn 
net), and on the signs and symptoms of infection. During the treatments with 
maggots, there were some complaints by the patient that the dressing design 
was not containing the maggots and that there was an increase in odor. He also 
noted that he could feel the maggots crawling around on his healthy tissue. 
After the fourth treatment with maggots, hydrotherapy was discharged 
secondary to the patient checking into the hospital for a second time. At this time 
the patient complained of a fever (102 OF), fatigue, chills, and shivers. His 
platelets were elevated secondary to the inflammatorylinfection phase reaction 
and blood cultures were positive for Staphylococcus aureus, Pseudomonas 
aeruginosa (multi-drug resistant), and Serratia. It was necessary to change the 
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type of antibiotics at this time from Piperacillin to Ampicillin Sulbactam and then 
finally to Meropenem to kill the infection. The day the patient checked into the 
hospital, he was kept on bed rest with the lower extremity elevated and was only 
allowed bathroom privileges. A hydrotherapy re-evaluation was performed on 
September 18, 1998, the day the patient was re-admitted to the hospital. 
The re-evaluation noted the size of the entire wound bed was 27 x 14 cm. 
The odor was fowl and there was 20% necrotic tissue and 80% granulation, 
although the granulated tissue was not a good color. The color of the wound was 
deep red/purple granulation with yellow/gray slough. Brownish purulent drainage 
was present. Edema was noted on the right medial and distal lower leg. ROM 
and se!lsation were not tested however the patient was assessed for crutches. 
Two new goals were set, 1) Accelerate healing process, 2) Monitor for infection. 
All of the maggots were removed and the wound was dressed with a wet to dry 
gauze dressing, Kerlix roll, and burn net. 
The day after the patient was admitted to the hospital with the infection 
and the re-evaluation was completed, hydrotherapy was continued. The patient 
was put in the Hubbard tank for twenty minutes and the wound was dressed with 
a wet-to-dry dressing, Kerlix, and burn net. Three days after the infection, a 
STSG was performed. There was 90% granulation in the wound bed prior to the 
graft being performed because it is important to have a clean, red wound with 
good circulation in .order for the graft to take. The skin graft was taken from the 
anterior and lateral surface of the patient's right thigh and was then placed on the 
open wound of the calf. A porcine xenograft (pig skin) was then placed on the 
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donor site of the thigh. Extra pieces of the graft taken from the thigh that were · 
not used were stored in a refrigerator in case portions of the graft did not take. 
The graft and donor site were left open to the air after the surgery and a mixture 
of rosewater and glycerin were sprayed onto the sites to keep them moist. The 
patient was instructed on "rolling" the sites with Q-tips to rid it of pus and to keep 
the graft level. The patient was on bed rest post-operatively. 
Two days after the STSG, the patient was seen by physical therapy for 
heel cord stretches, upper extremity blue thera-band exercises, and a footboard 
was put into place at the end of his bed to maintain the right foot in neutral. 
Three days after the STSG was performed, the patient was placed in the 
Hubbard tank again with no agitation for twenty minutes and then blotting was 
performed with a 4x4. The patient also began ambulation in hydrotherapy at this 
time. Six days after the graft was performed, it was necessary for the plastic 
surgeon to debride some areas of the wound where the graft did not take. The 
.remaining tissue graft that was stored in the refrigerator was re-applied to the 
debrided areas. The newly re-applied grafts did not take because it was felt that 
they were left in the refrigerator for too long. Although the graft did not take in 
certain areas of the wound, the wound managed to heal on its own. 
The remaining treatments in hydrotherapy included the Hubbard tank for 
twenty minutes, debridement with either a 4x4 or scissors and forceps, and 
dressing of an ABD pad and burn net. Eventually tubi-grip was used to help 
control any edema that was present. Prior to discharge from hydrotherapy, the 
wound measured 19.6 cm x 13 cm with good granulation present and migration 
41 
from the edges of the wound bed. The patient was discharged from physical 
therapy services at this time and was to continue with his plastic surgeon. 
Table 2 includes a summary of the subject's treatments and events from 
the time of the accident through to the time of discharge from physical 
therapy/hyd rotherapy. 
Table 2. Summary of the client's medical treatments and events 
8/30/98 
9/3/98 
9/3/98 to 9/9/98 
9/23/98 





Initial roth evaluation 
Hubbard tank x 20', SoftSorb dressing or Xeroform 
with ABO, burn net, ROM exercises, heel cord 
stretches 
Heel cord stretches, UIE exercises with blue thera-
band footboard on bed ut in ace 
Hubbard tank x 20' or whirlpool x 20', debridement 
with 4x4 (blotting) or scissors and forceps, Kerlix, 
liquid Elase, ABO, net, Santyl, Tubi-grip, "over the 
counter" Jobst (knee-high), ambulation, heel cord and 
hamstri stretches 
Discharge from hospital, outpatient status 
Areas of graft debrided and additional skin graft 
ed 




The history of maggot debridement therapy, biology, mechanisms of 
wound debridement, indications and contraindications of use, clinical application, 
dressing design, and the advantages and disadvantages were determined 
through the review of several journal articles and personal interviews. 
The patient included within the case study responded well to different 
treatment techniques implemented and was seen approximately one and a half 
months by hydrotherapy for a total of thirty-four treatment sessions. The total 
cost of treatment in hydrotherapy was approximately $6,005.00 and costs 
included one evaluation, one re-evaluation, Hubbard tank, whirlpool, semi-
selective debridement, and selective maggot debridement therapy. 
To record this patient's progress in hydrotherapy, measurements of the 
wound bed were, recorded. The amount of tissue granulation and necrosis were 
recorded before the split-thickness skin graft (STSG) was performed. Table 3 
shows how the four sessions of maggot therapy helped increase the amount of 
granulated tissue and decrease the amount of necrotic tissue and slough to help 
prepare the wound for the STSG. Table 4 shows the wound measurements 
taken during the initial evaluation, the re-evaluation, and at the time of the 
patient's discharge. 
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Table 3. Percentages of necrotic and granulated tissue throughout 
hydrotherapy 
9/3/98 (Initial Evaluation) Unable to assess 
9/6/98 
9/14/98*** 50% Necrotic 
9/15/98*** 50% Yellow/gray slough 
PTs unable to 
accurately assess at 
this time 
9/17/98*** 30-40% Yellow adherent >40% Granulation 
slou h, remaini is necrotic 




***Patient received Maggot Therapy from 9/9/98 to 9/18/98 
Table 4. Wound measurements throughout hydrotherapy treatment 
9/3/98 3 separate lacerations 
Initial PT evaluation • medial proximal = 2 x 4.2 cm 
• medial distal = 11 x 1.8 cm 
• most lateral = 27 x 4 cm 
9/18/98 27 x 14 cm 
PT re-evaluation 
10/16/98 19.6 x 13 cm 
Discha from PT 
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· A total of four sessions of maggot therapy were applied over a span of 
eleven days. An increase in the amount of tissue granulation was increased from 
50% to 90% in approximately eight days. Four days after maggot debridement 
therapy was complete, the wound bed was at 90% granulation and the wound 
bed was ready for the skin graft surgery. 
Figures 5 through 11 illustrate the wound's progression from September 4, 
1998 to October 16, 1998, the time of discharge from hydrotherapy. 
Figure 4. September 4, 1998 (five days after the bear attack). 
[The flap is sutured and three separate lacerations are present. 
The medial proximal laceration measures 2x4.2 cm, the medial 
distal laceration measures 11 x1.8 cm, and the lateral laceration 
measures 27x4 cm]. 
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Figure 5. September 8, 1998 (nine days after the attack). [One day 
before wound debrided in preparation for maggot debridement 
therapy. Maggot therapy initiated on September 9, 1998]. 
Figure 6. September 12, 1998 (thirteen days after the attack). 
[After one session of maggot therapy]. 
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Figure 7. September 14, 1998 (fifteen days after the attack). 
[After two sessions of maggot therapy, there is 50% granulation 
and 50% necrotic tissue present. The silvery-slimy tissue left 
behind by the maggots is visible]. 
Figure 8. September 17, 1998 (eighteen days after the attack) . 
[After three sessions of maggot therapy, there is greater than 40% 
granulation and 30 to 40% slough (the remaining is necrotic). The 
wound bed has good blood supply. Wound measures 27 x 14 cm]. 
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Figure 9. September 29, 1998 (thirty days after the attack). [The STSG 
was completed on September 21, 1998. Additional graft was placed over 
areas of the leg that did not take on September 27, 1998]. 
Figure 10. October 16, 1998 (forty-seven days after the attack). [Wound 
bed measures 19.6 x 13 cm and graft is healing nicely. Patient discharged 




To better understand the concept of maggot debridement therapy (MDT), 
it was first necessary to learn about the history of use, certain biological 
processes, and clinical applications. This background information aided in the 
process of reviewing the client's chart for the case study. By having a better 
understanding of the history, biology, mechanisms of wound healing, 
indications/contraindications, dressing design, advantages/disadvantages, 
clinicians can better explain it to their patients and appear, as well as feel, more 
confident with treatment sessions. 
The subject responded well to MDT two years ago in preparation for the 
soft tissue skin graft to his right lower leg. The amount of time in therapy was 
minimal when compared to several studies involving stubborn non-healing ulcers. 
The client was compliant with his treatment sessions, exercises, and stretches 
and he consented to MDT. The problem of infection did arise and delayed the 
healing process, as was expected by the physician. The wound's progression 
was monitored through measurements (length x width), percent granulation and 
necrosis, tracing onto a plastic grid, and with photographs. Photographs are an 
excellent way to monitor changes and they not only show changes in size, but in 
color toO.48 When using photographs, it is important to include an identification 
marker located next to the wound. The marker is made by taping a plastic 
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measuring sheet to a 3x5 card and then placing the card inside of a plastic 
sandwich bag. On the outside of the bag, the patient's identification, date, and 
location of wound can be written on a white tape to stick on the outside of the 
bag. Once the photograph is taken, the bag can be thrown away but the 3x5 
card is used again. Today, digital cameras exist that have computer software 
that performs the wound measurements as well as color monitoring. For uniform 
recording, it is important to keep the same distance from the camera to the 
wound. In this case study, the photographs do not have a measuring sheet 
located next to the wound in the photograph. This particular facility takes their 
pictures with a digital camera and then the images are saved on a computer. 
The measurements are taken with a disposable ruler and the measurements are 
recorded. I think that it is a good idea to have a measuring sheet in every picture 
because it is easier to compare photographs at a glance rather than having to 
look at measurements on another sheet. 
Certain assessment tools are available to monitor wound healing such as 
the 'Sussman Wound Healing Tool (SWHT) and the Pressure Sore Status Tool 
(PSST). The SWHT49 was developed to track the effectiveness of physical 
therapy technologies used for pressure sore ulcers. This tool is composed of two 
parts including ten tissue attributes and nine descriptive attributes of size. This 
tool was found to be reliable and clearly shows wound progression or risk. The 
documentation is simple and it is easy to use, taking approximately five minutes. 
This tool could be modified to include the type and amount of granulated or 
necrotic tissue, amount of slough, presence of odor, and if edema is present. 
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The Pressure Sore Status Tool (PSST) is another tool that should be considered 
as an assessment tool and it was found to be valid. 50 It is composed of 15 items 
that are scored from 1 to 5, except for size and location. The PSST appears to 
cover almost all areas of wound care and therefore would be helpful in the clinic, 
however both the SWHT and the PSST could be combined into one unique form. 
When using an assessment tool or if composing your own, important 
components should include: name, medical records number, examiner's name, 
dates, size (area), shape, depth/stage/edges, necrotic tissue (type, amount, 
slough), exudate (type, amount, odor, infection), granulation, contraction, 
undermining, epithelialization, color, edema, induration, maceration, hemorrhage, 
location (human body diagram to draw on), risk of skin breakdown, and the 
wound healing phase.48-5o 
An assessment tool, such as the SWHT and the PSST, were not used for 
the patient included within the case study. Although both of these tools are 
designated for pressure sores, it is felt that either, or a combination of both, could 
be used in a facility for any type of wound, even those including traumatic 
injuries. 
No studies with the use of MDT for a wound secondary to a bear attack 
could be located and most of the other studies reviewed involved patients with 
pressure sores, diabetes, or other debilitating conditions. One study of a 75-
year-old man suffering from Iymphostasis was located.2 Gangrene developed on 
his left leg below the knee and the wound was infected with Streptococcus 
aureus. The infection remained even after surgical debridement and disinfection 
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were performed. A skin graft could not be performed with the infection so MDT 
was initiated five days a week with the maggots left in place for 24 hours. Within 
two weeks, the entire infected area was clean and granulated tissue was present. 
After MDT was complete, the patient was referred for his autologous skin graft. 
Although this patient was older and more debilitated than the patient in this case 
study, the maggots cleansed the wound in two weeks and prepared the leg for a 
skin graft. The maggots in both cases were successful in preparing an infected 
lower leg wound for a skin graft in approximately the same amount of time. 
Limitations to this study are that the problem of infection, as anticipated by 
the patient's doctor, did arise and may have delayed the patient's healing time. 
The plastic surgeon who treated this patient retired recently and was not able to 
be contacted for questions. Another limitation was that the initial evaluation 
measured three different lacerations, whereas the final discharge note measured 
the entire open wound remaining after the STSG. This made it hard to compare 
. the initial evaluation to the patient's final discharge note from hydrotherapy, 
therefore progression was more easily noted by comparing the percent of tissue 
necrosis and granulation. The percent of tissue granulation and necrosis were 
not recorded on the first day of maggot debridement therapy (9/9/98) or on the 
second session of maggot therapy (9/12/98), making it hard to analyze the gains 
made with the maggots. No specific studies on a patient with a bear attack who 
received MDT was located and therefore it was difficult to compare this study's 
results to another resource. One final limitation to the study is that the wound 
bed was debrided by the plastic surgeon before the application of the maggots 
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and therefore the photographs make it look like the maggots debrided an 




Maggot debridement therapy (MDT) has been used as a form of wound 
treatment since the Civil War. The species of fly used today is Lucilia sericata or 
Phaenicia sericata, and a majority of wound types treated includes ulcers, 
pressure sores, and traumatic injuries. The history, biological processes, and 
clinical use rese'arched in this study are important for clinicians to understand 
when using MDT. This background information, in the form of a literature review, 
is presented in one concise resource and will be useful for those clinicians 
already using MDT in the clinic or for those clinicians or students who are 
interested in considering their use. The case study included presents how MDT 
was used after a traumatic accident to prepare an infected wound for a split-
thickness skin graft. Good results were achieved in what is felt was a minimal 
amount of time. The Wyoming facility protocol presented will allow other 
departments using MDT to compare their own protocol with the one presented 
here and to evaluate its effectiveness. 
The method of clinical application is one of trial and error and can depend 
on the supplies available in the clinic. The dressing design should be "cage-like" 
in order to contain the larvae. Patients need to be prepared for this type of 
therapy and therefore should have a thorough explanation before their treatment 
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begins. It is felt that the advantages outweigh the disadvantages and that this 
form of treatment can be used for many different cases. It has been felt that if 
MDT were used earlier in treatment, rather than as a last resort treatment, that 
even greater gains could be made in healing.46 This earlier application of 
maggots would prevent the need for topical or systemic antimicrobial treatment. 
If maggots have been effective enough to treat patients who otherwise may have 
lost limbs despite antibiotics and surgery, than we should use maggots before 
wounds progress that far. Clinical studies at the Veteran Affairs Medical Center 
and at the University of California22 are still underway, however they have 
already shown that MDT is more effective at cleaning infected and gangrenous 
wounds than any other non-surgical treatment anod that they clean wounds in ao 
shorter amount of time. With shorter treatment times, maggot debridement 
therapy can be considered cost-effective. Through the years the amount of 
coverage for patient treatments has decreased therefore presenting a challenge 
for physical therapists as well as other healthcare workers in providing 
treatments that are more effective. With shorter healing rates, the treatment 
costs for patients, as well as insurance agencies, will be less. If maggots are 
unable to initially be used as a treatment, than they should at least be considered 
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